IRIS UniCatt

Cicchetti, Americo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.463
NA - Nord America 6.642
AS - Asia 2.746
SA - Sud America 561
AF - Africa 148
OC - Oceania 92
Continente sconosciuto - Info sul continente non disponibili 16
Totale 19.668
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.441
IT - Italia 4.479
DE - Germania 1.453
SG - Singapore 998
SE - Svezia 975
CN - Cina 838
FR - Francia 553
BR - Brasile 487
UA - Ucraina 445
GB - Regno Unito 313
IE - Irlanda 295
ID - Indonesia 202
FI - Finlandia 161
IN - India 147
CA - Canada 142
NL - Olanda 138
RU - Federazione Russa 135
TR - Turchia 125
BE - Belgio 90
AU - Australia 75
PL - Polonia 72
ES - Italia 63
CH - Svizzera 62
IR - Iran 52
HK - Hong Kong 47
AT - Austria 44
KR - Corea 44
ZA - Sudafrica 34
VN - Vietnam 33
MX - Messico 29
MY - Malesia 29
TH - Thailandia 28
EG - Egitto 27
CZ - Repubblica Ceca 26
PH - Filippine 25
PT - Portogallo 25
NO - Norvegia 24
JP - Giappone 23
CO - Colombia 22
PK - Pakistan 21
BD - Bangladesh 18
AR - Argentina 17
KE - Kenya 17
LT - Lituania 17
NZ - Nuova Zelanda 17
TW - Taiwan 17
EU - Europa 15
GR - Grecia 15
IQ - Iraq 14
RO - Romania 13
MA - Marocco 12
SA - Arabia Saudita 11
AE - Emirati Arabi Uniti 10
EC - Ecuador 9
ET - Etiopia 9
HN - Honduras 9
LV - Lettonia 9
PE - Perù 9
SI - Slovenia 9
DZ - Algeria 8
JO - Giordania 8
BG - Bulgaria 7
CL - Cile 7
AZ - Azerbaigian 6
CI - Costa d'Avorio 6
HR - Croazia 6
IL - Israele 6
JM - Giamaica 6
LB - Libano 6
MD - Moldavia 6
MZ - Mozambico 6
DK - Danimarca 5
CR - Costa Rica 4
EE - Estonia 4
HU - Ungheria 4
NP - Nepal 4
UY - Uruguay 4
UZ - Uzbekistan 4
BN - Brunei Darussalam 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GH - Ghana 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MK - Macedonia 3
MW - Malawi 3
NA - Namibia 3
NG - Nigeria 3
QA - Qatar 3
RS - Serbia 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
VE - Venezuela 3
AM - Armenia 2
BO - Bolivia 2
CM - Camerun 2
GE - Georgia 2
KH - Cambogia 2
KW - Kuwait 2
Totale 19.636
Salva come PNG Salva come JPEG
Città #
Chandler 1.039
Rome 547
Singapore 539
Milan 527
Ashburn 451
Ann Arbor 333
Jacksonville 321
Dublin 286
San Mateo 213
Jakarta 168
Cattolica 161
Wilmington 145
Nanjing 140
New York 118
Woodbridge 118
Plan 117
Marseille 114
Redwood City 109
Chicago 107
Frankfurt am Main 100
Dearborn 98
Los Angeles 95
Boston 92
Houston 89
Bologna 87
Munich 79
Beijing 78
The Dalles 78
Moscow 77
Fairfield 76
Boardman 73
Mountain View 73
Lawrence 71
Bremen 70
Seattle 69
Brussels 68
Princeton 68
Bari 65
Turin 62
Nanchang 61
Helsinki 55
Naples 51
Nürnberg 51
Lancaster 47
Paris 45
Izmir 43
Salt Lake City 43
Shanghai 40
Hefei 39
Florence 38
Torino 37
London 36
Palermo 35
Augusta 34
Ottawa 34
Seoul 34
Redmond 32
São Paulo 32
Trieste 32
Frattamaggiore 30
Hangzhou 30
Shenyang 28
Kuala Lumpur 27
Modena 27
Pune 27
Cambridge 26
Changsha 26
Falls Church 26
Vienna 26
Warsaw 26
Hong Kong 25
Tianjin 25
Amsterdam 24
Andover 24
Dallas 24
Genoa 24
Norwalk 24
Padova 24
Toronto 24
Leawood 23
Verona 23
Buffalo 22
Düsseldorf 22
Kunming 21
Bangkok 20
Catania 20
Moncalieri 20
Pisa 20
Trento 20
Brescia 19
Elk Grove Village 19
Guangzhou 19
Nutley 19
Ankara 18
Brooklyn 18
Fremont 18
Jiaxing 18
Lauterbourg 18
Perugia 18
Brasília 17
Totale 8.869
Salva come PNG Salva come JPEG
Nome #
Return-on-Investment of Workplace Health Promotion programs: New Total Worker Health® strategies in the framework of the “One Health” approach 889
I costi socio-sanitari dell’insufficienza renale cronica 664
Igiene, Medicina Preventiva, Sanità Pubblica. Seconda Edizione 637
The AdHopHTA handbook: a handbook of hospital-based Health Technology Assessment (HB-HTA) 633
Innovazione organizzativa e ruoli emergenti in sanità 475
Dealing with COVID-19 epidemic in Italy: Responses from regional organizational models during the first phase of the epidemic 465
L'analisi dei network organizzativinei sistemi sanitari: il caso della rete di emergenza della Regione Lazio 352
Un innovativo incentivo per aumentare l’aderenza alla vaccinazione antinfluenzale tra gli operatori sanitari: analisi cost-consequence e valutazione di sostenibilità. 309
Measuring organizational performance. A review of the dimensions of hospital performance indicators [Pitch presentation] 288
Innovazione organizzativa e ruoli emergenti in sanità 281
Misurare le prestazioni organizzative. Revisione delle dimensioni degli indicatori di performance ospedaliera [Poster] 251
HTA of alternative methods of pathogen inactivation of fresh frozen plasma 244
Flu vaccination and value-based health care: operational solutions to safeguard public health 228
NutriCatt protocol in the enhanced recovery after surgery (ERAS) program for colorectal surgery: the nutritional support improves clinical and cost-effectiveness outcomes. 214
Economia sanitaria 200
Full HTA di Emicizumab 191
The ethical assessment in HTA reports: the development and the evolution of the ethics consultation by Institute of Bioethics of the Università Cattolica del Sacro Cuore, Rome (Italy) 188
IL RUOLO DELL’HEALTH TECHNOLOGY ASSESSMENT NELLA DEFINIZIONE DEI LIVELLI ESSENZIALI DI ASSISTENZA 185
Economia sanitaria 183
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 175
How could Ethical, Legal, Social & Organizational issues be further integrated in HTA processes? A proposal of “extended” ELSI logics: justifications and considerations moving from the debate and the experience. 174
Copertura vaccinale antinfluenzale e assenteismo per malattia negli Operatori Sanitari di un Policlinico Universitario Italiano 174
Il ruolo degli stakeholder nel processo di Health Technology Assessment 166
The “triangular model” applied to drug eluting stents (DES) 162
Factors associated with health-related quality of life: the role of social relationships among the elderly in an Italian region 160
L'HB-HTA: esperienze, buone pratiche e strumenti del progetto europeo AdHopHTA 159
Il caso del Policlinico A. Gemelli 156
Hospital contextual factors affecting the use of health technologies: a systematic review [Poster display] 154
La definizione delle priorità nel processo di HTA. Tra esigenze centrali e regionali 151
Health Technology Assessment di ausili assorbenti per l’incontinenza urinaria 149
Lo sviluppo della consulenza etica nei processi di HTA: i dati preliminari dell'esperienza dell'Istituto di Bioetica dell'Università Cattolica del Sacro Cuore (Roma) 146
Cost Effectiveness Analysis of Instanyl for the Treatment of Breakthrough Cancer Pain (BtcP) 142
Health Technology Assessment and vaccine: new needs and opportunities? 141
Return on investment (ROI) and development of a workplace disability management program in a hospital—a pilot evaluation study 141
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 137
The ethical relevance of explainibility for AI-solutions for early diagnosis of dementia 136
Use of robot-specific resources and operating room times: the case of Telelap Alf-X robotic hysterectomy 134
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use 133
INDIVIDUARE, FINANZIARE E COMUNICARE L’INNOVAZIONE IN SANITÀ: IL RUOLO DELL’HEALTH TECHNOLOGY ASSESSMENT 132
Il modello WEF per la valutazione economica delle innovazioni terapeutiche in epatologia. 131
Organizational Models of Hospital Based HTA: Empirical Evidence from Adhophta European Project 130
Balanced Scorecard for performance assessment in healthcare settings: a review of literature 130
Prioritization of high-cost new drugs for HCV: making sustainability ethical 128
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 127
EXPLORING THE ROLE OF PROFESSIONAL NETWORKS ON THE DIFFUSION OF MEDICAL TECHNOLOGIES: AN EMPIRICAL STUDY ON ROBOTIC SURGERY 127
Health Technology Assessment of the anti HCV strategies in Italy: evidences from the WEF Project 122
Diffusione dei modelli dipartimentali nelle aziende sanitarie italiane 119
Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors 118
Healthcare expenditure on prevention in the spending review era 118
The harmonic study: cost-effectiveness evaluation of the use of the ultrasonic scalpel in total thyroidectomy 113
Il dipartimento non è di carta 110
The diffusion and impact of the divisional model in Italian National Health service Hospitals 110
Hta e decision making: proposte e risultati dell’Health policy forum 110
Healthcare Reform, Quality and Safety. Perspectives, Participants and Prospects in 30 countries 110
Assessing social and Economic Impact of Subcutaneous Mabs in Oncology 110
Money back guarantee? A cost–benefit framework of performance-based agreements (PBAs) for the reimbursement of pharmaceuticals 110
L'approccio metodologico 109
La diffusione del modello dipartimentale nel SSN: un fatto solo formale? 108
Descrizione degli Indicatori e Fonti dei dati 108
Investigating the generalizability of Economic Evaluations conducted in Italy: a critical review 106
Descrizione degli Indicatori e Fonti dei dati 104
The use of harmonic scalpel versus knot tying for conventional open thyroidectomy: results of a prospective randomized study 102
MONITORING REGISTRIES AT ITALIAN MEDICINES AGENCY: FOSTERING ACCESS, GUARANTEEING SUSTAINABILITY. 102
Il punto di vista delle aziende 100
Assessing social and economic impact of subcutaneous mAbs in oncology 100
Health technology assessment in Italy 99
Valutazione economica dei programmi di screening contro il cancro del colon retto: evidenze indirette di lungo periodo e sostenibilita` finanziaria in un’ottica di programmazione regionale 98
Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors 98
Unfolding similarity in interphysician networks: the impact of institutional and professional homophily 98
Unfolding similarity in interphysician networks: the Impact of Institutional and Professional Homophily 98
Linking the Price of Cancer Drug Treatments to Their Clinical Value 97
Descrizione degli Indicatori e Fonti dei dati 96
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 96
Valutazione multidimensionale e multidisciplinare del servizio di consegna domiciliare dei presidi medici per stomia e incontinenza 96
Harmonic study: A cost-effectiveness evaluation of ultrasonically activated shears for total thyroidectomy [Lo studio HARMONIC: Valutazione costo-efficacia dell'uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale] 95
Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system 95
Extending influenza vaccination to individuals aged 50–64: A budget impact analysis 94
Cost-consequence analysis of influenza vaccination among the staff of a large teaching hospital in Rome, Italy: A pilot study 94
Telemedicine Has a Social Impact: An Italian National Study for the Evaluation of the Cost-Opportunity for Patients and Caregivers and the Measurement of Carbon Emission Savings 94
Hospital restructuring and physician job satisfaction: An empirical study 93
Il ruolo delle competenze dei rappresentanti dei cittadini: evidenze dalle associazioni italiane dedite all'advocacy 93
Economic assessment of Zostavax vaccine for the prevention of Herpes Zoster 92
Activity-based costing analysis of the analgesic treatments used in postoperative pain management in Italy. 91
The cost-effectiveness of alternative strategies against HBV in Italy 90
Looking good or doing better? Patterns of decoupling in the implementation of Clinical Directorates 90
GUIDING PRINCIPLES FOR GOOD PRACTICES IN HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT UNITS. 90
L’utilizzo di modelli decisionali per le valutazioni economiche dei farmaci in Italia: stato dell’arte e prospettive future 89
A new decision model for economic evaluation of novel therapies for HCV 89
Looking good or doing better? Patterns of decoupling in the implementation of clinical directorates. 87
Come comunicare e trasferire i risultati delle valutazioni di HTA applicata alle vaccinazioni ai decision makers e agli stakeholders? il progetto dell’ISPOR Rome chapter 86
L’ECOSISTEMA HTA A LIVELLO EUROPEO 86
Assessing hospital performance indicators. What dimensions? Evidence from an umbrella review 85
Ruolo e Regole degli stakeholder nel processo di HTA. Le Evidenze emerse dall’Health Policy Forum della SIHTA 84
Sustainability of a public system for plasma collection, contract fractionation and plasma-derived medicinal product manufacturing 84
Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory. 84
Economic assessment of an anti-HCV screening program in Italy 83
"Us and Them": a social network analysis of physicians' professional networks and their attitudes towards EBM 82
Hospital contextual factors affecting the implementation of health technologies: a systematic review 82
Assessing hospital performance indicators. What dimensions? Evidence from an umbrella review 81
COVERAGE UNDER EVIDENCE DEVELOPMENT: L’ESPERIENZA DELL’HEALTH POLICY FORUM 81
Totale 16.031
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.189
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020145 0 0 0 0 0 0 0 0 0 0 0 145
2020/20211.688 133 221 59 150 184 110 134 81 211 94 227 84
2021/20221.993 145 130 56 105 174 79 132 250 113 166 322 321
2022/20233.728 429 431 285 523 248 391 223 332 402 140 221 103
2023/20242.878 145 514 116 238 175 305 205 239 143 212 306 280
2024/20254.699 172 209 359 274 454 240 251 246 583 434 913 564
Totale 19.944